Why Is NervGen Pharma Stock Gaining Tuesday? - NervGen Pharma (NASDAQ:NGEN)

NGEN stock climbs as NervGen Pharma NVG-291 hits a 100% responder rate in spinal cord injury gait analysis. Phase 3 set for mid-2026.

Raccontata dabenzinga.com